What is LOPJLB’s current signal on PTGX?

LOPJLB’s latest quantitative signal on Protagonist Therapeutics, Inc. (PTGX) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is PTGX in?

Protagonist Therapeutics, Inc. (PTGX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Protagonist Therapeutics, Inc. (PTGX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$136.28-1.60%Close

SELLRECOVERY · day 4

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONECOILBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $8.8B
Beta: 1.79
P/E (TTM): 111.88

Short % float: 17.80%
Days to cover: 11.5
SI change: +14.8%

1W: -3.29%
1M: -4.97%

vs SPY 1W: -3.15%
vs SPY 1M: -7.47%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders. The company's…

Employees: 141
Headquarters: US
Founded: 2016
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 64.3M
Float: 81.6%

protagonist-inc.com ↗

Key executives

Dinesh V. Patel — Chief Executive Officer, President, Secretary & Director

Arturo Molina FACP — Chief Medical Officer

Asif Ali — Executive Vice President & Chief Financial Officer

SEC filings

EDGAR · CIK 13771210 · PTGX

Analyst consensus

Buy

Bullish26100.0%

Neutral00.0%

Bearish00.0%

L $165.00Avg $177.25H $190.00

Target$177.25+30.06%

Last$136.28

FAQ

What is LOPJLB’s current signal on PTGX?: LOPJLB’s latest quantitative signal on Protagonist Therapeutics, Inc. (PTGX) is SELL in a RECOVERY regime. Signals are updated daily.
What market regime is PTGX in?: Protagonist Therapeutics, Inc. (PTGX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
What does Protagonist Therapeutics, Inc. (PTGX) do?: Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders. The company's pipeline features rusfertide (PTG-300), an injectable hepcidin mimetic currently undergoing Phase II clinical trials f…

Key stats

Industry peers

Prediction markets

Company news

FAQ